These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24991974)

  • 1. Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men.
    McDonnell J; Haddow L; Daskalopoulou M; Lampe F; Speakman A; Gilson R; Phillips A; Sherr L; Wayal S; Harrison J; Antinori A; Maruff P; Schembri A; Johnson M; Collins S; Rodger A;
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):120-7. PubMed ID: 24991974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
    Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
    PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the role of peripheral CD8 T cells in neurocognitive impairment in HIV-infected men who have sex with men: data from the MSM Neurocog Study.
    Rawson TM; Dubb S; Pozniak A; Kelleher WP; Mandalia S; Gazzard B; Barber TJ
    Int J STD AIDS; 2015 Feb; 26(2):128-32. PubMed ID: 24759562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
    Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
    BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients.
    Haddow LJ; Laverick R; Daskalopoulou M; McDonnell J; Lampe FC; Gilson R; Speakman A; Antinori A; Balestra P; Bruun T; Gerstoft J; Nielsen L; Vassilenko A; Collins S; Rodger AJ;
    AIDS Behav; 2018 May; 22(5):1573-1583. PubMed ID: 28144792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual behaviours, HIV testing, and the proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000-13: a serial cross-sectional study.
    Aghaizu A; Wayal S; Nardone A; Parsons V; Copas A; Mercey D; Hart G; Gilson R; Johnson AM
    Lancet HIV; 2016 Sep; 3(9):e431-e440. PubMed ID: 27562744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Wright EJ; Grund B; Cysique LA; Robertson KR; Brew BJ; Collins G; Shlay JC; Winston A; Read TR; Price RW;
    HIV Med; 2015 Apr; 16 Suppl 1():97-108. PubMed ID: 25711328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An explanatory factor analysis of a brief self-report scale to detect neurocognitive impairment among HIV-positive men who have sex with men and transgender women in Peru.
    Weikum D; Shrestha R; Ferro EG; Vagenas P; Copenhaver M; Spudich S; Alpert MD; Cabello R; Lama JR; Sanchez J; Altice FL
    AIDS Care; 2017 Oct; 29(10):1297-1301. PubMed ID: 28449599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
    Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
    J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine detection and management of neurocognitive impairment in HIV-positive patients in a UK centre.
    Haddow LJ; Accoroni A; Cartledge JD; Manji H; Benn P; Gilson RJ
    Int J STD AIDS; 2013 Mar; 24(3):217-9. PubMed ID: 23535355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of HIV exposure and excess burden of neurocognitive impairment in people living with HIV: a protocol for systematic review and meta-analysis of controlled studies.
    Ayu AP; Rahadi A; Kristian K; Sani TP; Putra A; Halim G; Mangkuliguna G; Kusumoputri TP; Turana Y
    Syst Rev; 2023 Nov; 12(1):214. PubMed ID: 37968747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada.
    Robertson K; Bayon C; Molina JM; McNamara P; Resch C; Muñoz-Moreno JA; Kulasegaram R; Schewe K; Burgos-Ramirez A; De Alvaro C; Cabrero E; Guion M; Norton M; van Wyk J
    AIDS Care; 2014; 26(12):1555-61. PubMed ID: 25029599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
    Ding Y; Lin H; Shen W; Wu Q; Gao M; He N
    J Neuroimmune Pharmacol; 2017 Dec; 12(4):661-669. PubMed ID: 28470583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort.
    Moore DJ; Roediger MJ; Eberly LE; Blackstone K; Hale B; Weintrob A; Ganesan A; Agan BK; Letendre SL; Crum-Cianflone NF
    PLoS One; 2012; 7(11):e47310. PubMed ID: 23144815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research.
    Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ
    J Neurovirol; 2014 Jun; 20(3):258-68. PubMed ID: 24696363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, Uganda.
    Kisakye A; Saylor D; Sacktor N; Nakigozi G; Nakasujja N; Robertson K; Anok A; Wawer M; Gray R
    AIDS Care; 2019 Jul; 31(7):836-839. PubMed ID: 30554522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.